Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2012
02/02/2012US20120028955 Bicyclic mglur5 positive allosteric modulators and methods of making and using same
02/02/2012US20120028954 Substituted Pyridine, Pyridazine, Pyrazine And Pyrimidine Compounds And Methods For Using The Same
02/02/2012US20120028953 Azetidine Derivatives
02/02/2012US20120028952 5-alkynyl-pyrimidines
02/02/2012US20120028951 Pyridazinone compounds
02/02/2012US20120028938 Pyrazole compounds as crth2 antagonists
02/02/2012US20120028931 Heterocyclic m-glu5 antagonists
02/02/2012US20120028924 Chemical compounds
02/02/2012US20120028907 Methods for identification of tumor phenotype and treatment
02/02/2012US20120028249 Anthraquinone based near ir emitting compounds and uses thereof
02/02/2012US20120027842 Topical formulations of flap inhibitors for administration to an eye
02/02/2012US20120027741 Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
02/02/2012US20120027682 Pyrazine Derivatives for Optical Imaging and Therapy
02/02/2012US20120025183 Novel organic compound, light-emitting device, and image display apparatus
02/02/2012CA2809113A1 P2x4 receptor antagonist
02/02/2012CA2806821A1 Fused ring pyridine compound
02/02/2012CA2806766A1 Therapeutic agent for neurological diseases
02/02/2012CA2806701A1 Process for the synthesis of substituted urea compounds
02/02/2012CA2806341A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012CA2806332A1 Quinoline derivatives and melk inhibitors containing the same
02/02/2012CA2806008A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
02/02/2012CA2805078A1 Imidazole derivatives
02/02/2012CA2805043A1 Hetero-bicyclic derivatives as hcv inhibitors
02/02/2012CA2804355A1 Novel microbiocidal dioxime ether derivatives
02/02/2012CA2803689A1 Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms
02/02/2012CA2803387A1 Cyclic amine azaheterocyclic carboxamides
02/01/2012EP2412713A1 Pyrazole compound
02/01/2012EP2412708A1 Substituted 3-hydroxy-4-pyridone derivative
02/01/2012EP2411381A1 Substituted spiro-amide compounds
02/01/2012EP2411380A1 Process for the preparation of desloratadine
02/01/2012EP2411379A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
02/01/2012EP2411369A1 Fluoroquinolone carboxylic acid molecular crystals
02/01/2012EP2411368A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
02/01/2012EP2411365A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
02/01/2012EP2411364A1 Anticancer compounds, preparation thereof, and therapeutic use thereof
02/01/2012EP2411363A1 Substituted piperidines as par-1 antagonists
02/01/2012EP2411361A1 1,1,1-trifluoro-2-hydroxypropyl compounds
02/01/2012EP2411012A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
02/01/2012EP2411011A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
02/01/2012EP2411010A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
02/01/2012EP2411001A1 P2x3, receptor antagonists for treatment of pain
02/01/2012EP2410855A1 Process for the preparation of alogliptin
02/01/2012EP2410844A1 Inhibitors of hepatitis c virus replication
02/01/2012EP2265601B1 Pyridazine derivatives as factor xia inhibitors
02/01/2012EP2212287B1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
02/01/2012EP2130827B1 Method for producing quinolone carboxylic acid derivative
02/01/2012EP2081922B1 5,6-Ring annulated indole derivatives and use thereof
02/01/2012EP2079735B1 N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression.
02/01/2012EP2064204B1 Inhibitors of 5 -lipoxygenase activating protein ( flap)
02/01/2012EP2049475B1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
02/01/2012EP1833794B1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
02/01/2012EP1817301B1 Potentiators of glutamate receptors
02/01/2012CN102341388A Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
02/01/2012CN102341387A Tetrazoyl oxime derivative, salt thereof, and plant disease control agent
02/01/2012CN102341386A Pyridine derivative
02/01/2012CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase
02/01/2012CN102341384A P38 map kinase inhibitors
02/01/2012CN102341383A Inhibitors of Bruton's Tyrosine Kinase
02/01/2012CN102341382A Heterocyclic antiviral compounds
02/01/2012CN102341376A 3-arylquinazolin-4-one compounds for combating invertebrate pests
02/01/2012CN102341371A Bis aromatic compounds for use as lct4 synthase inhibitors
02/01/2012CN102336788A Glucosamine double salt for proton pump inhibitor
02/01/2012CN102336749A Allosteric modulators of metabotropic glutamate receptors
02/01/2012CN102336741A Fluorine-18-marked myocardial perfusion developing agent and preparation method and application thereof
02/01/2012CN102336740A Novel imidazole compound and its application
02/01/2012CN102336739A Loratadine compound and preparation method thereof
02/01/2012CN102336716A 嘧啶衍生物 Pyrimidine derivatives
02/01/2012CN102336715A Trifluoromethyl-substituted pyridazine derivative biological kinase inhibitor and application thereof
02/01/2012CN102335173A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/01/2012CN101817784B 乙烯衍生物和含有该衍生物的杀有害生物剂 Ethylene derivative and the pesticidal agent containing the derivative
02/01/2012CN101528709B 对痕量胺相关受体有亲和性的氨基甲基-2-咪唑类 The trace amine associated receptors have affinity for the amino-methyl-2-imidazole
02/01/2012CN101068806B (s)-(-)-1-(4-氟代异喹啉-5-基)磺酰基-2-甲基-1,4-高哌嗪盐酸盐-二水合物 (S) - (-) - 1- (4- fluoro-isoquinolin-5-yl) sulfonyl-2-methyl-1,4-homopiperazine hydrochloride - dihydrate
01/2012
01/31/2012US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
01/31/2012US8106210 Polymorphs of esomeprazole salts
01/31/2012US8106208 Benzamide compounds that act as NK receptor antagonists
01/31/2012US8106206 Solid luminescent quinoline compounds
01/31/2012US8106197 Aminoheteroaryl compounds as protein kinase inhibitors
01/31/2012US8106193 Luminophores
01/31/2012US8106191 Compounds based on N- acyl-pipecolyl and N-acyl-prolyl ligand moieties for multimerizing chimeric proteins containing immunophilin-derived domains
01/31/2012US8106088 Fused bicyclic-substituted amines as histamine-3 receptor ligands
01/31/2012US8106076 Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
01/31/2012US8106075 insecticide for representatives of the order Acarina; protection of plant propagation material from the attack by pests; N-(4-chloro-2-methyl-6-[([oxetan-2-ylmethyl]amino)carbonyl]phenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
01/31/2012US8106072 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative
01/31/2012US8106070 Substituted imidazoles as bombesin receptor subtype-3 modulators
01/31/2012US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
01/31/2012US8106055 Substituted amide compounds
01/31/2012US8106051 Utilities of amide compounds
01/31/2012US8106048 protozoal infestations in humans and animals, by bacteria, viruses or proteinaceous agents; neurological diseases or disorders; ischemia and/or reperfusion injury; 4-(4-Ethoxycarbonyl-4,5-dihydro-thiazol-2-yl)-piperidine-1-carboxylic acid t-butyl ester
01/31/2012CA2504718C Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
01/31/2012CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
01/26/2012WO2012012619A1 Protein kinase c inhibitors and uses thereof
01/26/2012WO2012012612A2 Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes
01/26/2012WO2012012543A1 Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders
01/26/2012WO2012012542A1 Methods of use of cyclic amide derivatives to treat schizophrenia
01/26/2012WO2012012528A1 Insecticidal triazines and pyrimidines
01/26/2012WO2012012410A2 Kappa opioid receptor agonists
01/26/2012WO2012012366A1 Pesticidal 3-(aryloxy)azacycloalkanes
01/26/2012WO2012011847A1 Substituted indoles, antiviral active component, method for producing and using same
01/26/2012WO2012011707A2 Substituted pyridinone derivatives and methods for manufacturing the same
01/26/2012WO2012011592A1 Heterocyclic compound and application thereof